等待開盤 10-08 09:30:00 美东时间
+0.020
+0.10%
今日重点评级关注:Ascendiant Capital:维持Aytu BioPharma"买入"评级,目标价从14.5美元升至15美元;摩根大通:维持Annexon"超配"评级,目标价从14美元升至15美元
10-01 19:18
TD Cowen analyst Andrew Kligerman downgrades Accelerant Hldgs (NYSE:ARX) from Buy to Hold and lowers the price target from $30 to $20.25.
09-30 18:56
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page. Raymond James analyst C. Gregory Peters downgraded Accelerant Holdings (NYSE:ARX) from Market Per...
09-23 21:09
Accelerant Holdings Class A ( ($ARX) ) has shared an update. On September 23, 2...
09-23 20:58
Raymond James analyst C. Gregory Peters downgrades Accelerant Hldgs (NYSE:ARX) from Market Perform to Underperform.
09-23 17:50
Insiders may stand to receive substantial financial benefits not available to ordinary shareholders. The proposed transactions may contain terms that could limit superior competing offers. S...
08-24 19:47
量子计算概念昆腾飙涨117%!实现近三年来首度单季非GAAP盈利;“AI超级牛股”NEBIUS周内暴涨48%!AI云收入迎爆发式增长>>
08-15 10:30
XChange飙升348%,拟收购智能体公司加速AI保险转型;ARX劲升43%,获私募溢价近5成收购;奥麦罗制药升逾26%,Q2业绩强劲,EPS扭亏为盈大超预期>>
08-14 16:05
William Blair analyst Adam Klauber downgrades Accelerant Hldgs (NYSE:ARX) from Outperform to Market Perform.
08-14 05:33
Insiders may stand to receive substantial financial benefits not available to ordinary shareholders. The proposed transactions may contain terms that could limit superior competing offers. S...
08-14 03:04